Skip to the guide
Let your plan answer

Will insurance pay for this plan?

Give your health plan the medicine’s exact name and ask about coverage for the condition prompting the prescription. Keep its answer separate from a service’s cash offer.

U.S. care context: September 2026.

Words your plan may use

Ask what “covered” means in your case

Your health plan’s list of covered medicines is called its formulary.

Prior authorization means the plan reviews a request before agreeing to pay.

Medicare’s usual medicine coverage

The reason for treatment changes the question

In September 2026, medicines taken solely for weight loss are excluded from Medicare Part D, Medicare’s usual coverage for prescription medicines.

Part D may cover a medicine prescribed for another accepted medical condition; your plan’s medicine list and approval steps still apply.

A temporary payment route

Ask whether the Medicare Bridge applies

Here, GLP-1 means a group of weight and diabetes medicines: Ozempic and Wegovy are semaglutide brands; Mounjaro and Zepbound are tirzepatide brands.

As of September 2026, people who meet the Medicare GLP-1 Bridge’s rules pay $50 a month for certain weight medicines.

This temporary program runs from July 1, 2026, through December 31, 2027.

The Part D yearly limit caps what you pay yourself for covered medicines. Bridge payments do not help you reach that limit. The Bridge also provides no extra help for people with low incomes.

Discounts and cash offers

Check which offer is on the table

A savings card is a drug company discount used with private or workplace insurance.

For September 2026, savings cards for semaglutide brands Ozempic and Wegovy and tirzepatide brands Mounjaro and Zepbound require private or workplace insurance.

Those cards exclude Medicare and Medicaid.

Drug companies also offer prices for people who pay without insurance. Those offers may be available to people with Medicare or other government coverage.

Read with a purpose

A short reading list